Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Ann Surg Oncol. 2012 Nov 10;20(6):1788–1797. doi: 10.1245/s10434-012-2741-4

Table 2. Geriatric Assessment Findings.

Stages I and II Stage III Total p value
N (%) N (%) N (%)
Functional status
 Activities of daily living (ADL)
  Needs assist (<7) 6 (11.1) 2 (4.2) 8 (7.8) 0.276
  Independent 48 (88.9) 46 (95.8) 94 (92.2)
 Instrumental activities of daily living (IADL)
  Needs assist (<14) 15 (27.8) 17 (34.7) 32 (31.1) 0.525
  Independent 39 (72.2) 32 (65.3) 71 (68.9)
 Timed up and go
  <10 seconds 44 (81.5) 33 (67.3) 77 (74.8) 0.116
  ≥10 seconds 10 (18.5) 16 (32.7) 26 (25.2)
 Karnofsky performance status—rated by healthcare team
  Unable to work, lives at home (50–70) 8 (14.8) 8 (16.3) 16 (15.5) 1.000
  Normal activities (80–100) 46 (85.2) 41 (83.7) 87 (84.5)
 Karnofsky performance status-self-reported by patients
  Unable to work, lives at home (50–70) 2 (3.7) 6 (12.2) 8 (7.8) 0.146
  Normal activities (80–100) 52 (96.3) 43 (87.8) 95 (92.2)
 Routinely exercise
  Yes 20 (38.5) 24 (50.0) 44 (44.0) 0.314
  No 32 (61.5) 24 (50.0) 56 (56.0)
Cognition
 Blessed Orientation-Memory-Concentration Test
  Possible impairment (≥ 11) 1 (1.9) 1 (2.0) 2 (1.9) 1.000
  Normal (<11) 53 (98.1) 48 (98.0) 101 (98.1)
Comorbidity
 Previous cancer Dx
  Yes 16 (29.6) 13 (26.5) 29 (28.2) 0.827
  No 38 (70.4) 36 (73.5) 74 (71.8)
 Other chronic illness
  Yes 50 (92.6) 41 (83.7) 91 (88.3) 0.221
  No 4 (7.4) 8 (16.3) 12 (11.7)
Nutrition
 Body mass index: weight/height2
  Normal weight 21 (38.9) 22 (44.9) 43 (41.7) 0.277
  Overweight 17 (31.5) 19 (38.8) 36 (35.0)
  Obese 16 (29.6) 8 (16.3) 24 (23.3)
 Weight increase or decrease over 6 months
  Increase 3 (42.9) 8 (72.7) 11 (61.1) 0.332
  Decrease 4 (57.1) 3 (27.3) 7 (38.9)
 Food intake in the past month
  Unchanged 41 (75.9) 29 (60.4) 70 (68.6) 0.07
  More than usual 2 (3.7) 8 (16.7) 10 (9.8)
  Less than usual 11 (20.4) 11 (22.9) 22 (21.6)